Granules India Limited has received the Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency (PMDA), Japan for its Jeedimetla facility, located at Jeedimetla, Quthbullapur Mandal, Medchal-Malkajgiri District, Hyderabad, Telangana. The certification has been received for accreditation categories of non-sterile Drugs, Packaging, Labelling and Storage of Drugs. Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
429.1 INR | +0.54% | +8.32% | +5.85% |
05-15 | Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024 | |
05-15 | Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.85% | 1.24B | |
+39.83% | 723B | |
+34.28% | 595B | |
-4.03% | 369B | |
+20.42% | 332B | |
+2.97% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.09% | 168B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India Limited Receives Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency